We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$41.6B
AUM Growth
+$4.19B
Cap. Flow
+$2.15B
Cap. Flow %
5.18%
Top 10 Hldgs %
17.44%
Holding
1,483
New
402
Increased
470
Reduced
298
Closed
268

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$493M
2
WBA
Walgreens Boots Alliance
WBA
+$361M
3
V icon
Visa
V
+$291M
4
CRM icon
Salesforce
CRM
+$278M
5
STZ icon
Constellation Brands
STZ
+$254M

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 17.07%
3 Financials 14.54%
4 Consumer Discretionary 11.34%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLFC icon
1151
Willis Lease Finance
WLFC
$1.37B
$255K ﹤0.01%
30,621
-6,300
-17% -$52.4K
TT icon
1152
Trane Technologies
TT
$106B
$250K ﹤0.01%
2,800
-61,700
-96% -$5.44M
ADAP
1153
DELISTED
Adaptimmune Therapeutics
ADAP
$244K ﹤0.01%
+36,588
New +$283K
ABG icon
1154
Asbury Automotive
ABG
$3.92B
$243K ﹤0.01%
3,803
+203
+6% +$12.7K
FBK icon
1155
FB Financial Corp
FBK
$3.05B
$239K ﹤0.01%
+5,700
New +$231K
SNR
1156
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$239K ﹤0.01%
+31,600
New +$264K
SAUC
1157
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$238K ﹤0.01%
148,954
-8,410
-5% -$13.6K
IVAC
1158
DELISTED
Intevac Inc
IVAC
$236K ﹤0.01%
34,400
-5,942
-15% -$45.6K
GEL icon
1159
Genesis Energy
GEL
$1.88B
$235K ﹤0.01%
+10,500
New +$243K
BPMC
1160
DELISTED
Blueprint Medicines
BPMC
$234K ﹤0.01%
+3,100
New +$218K
TTSH
1161
DELISTED
Tile Shop Holdings
TTSH
$233K ﹤0.01%
24,273
-36,727
-60% -$324K
GLOP
1162
DELISTED
GASLOG PARTNERS LP
GLOP
$233K ﹤0.01%
+9,400
New +$218K
ORM
1163
DELISTED
Owens Realty Mortgage, Inc.
ORM
$233K ﹤0.01%
14,523
AES icon
1164
AES
AES
$10.5B
$231K ﹤0.01%
21,300
-985,500
-98% -$10.7M
ALG icon
1165
Alamo Group
ALG
$2.03B
$231K ﹤0.01%
2,049
-5,236
-72% -$585K
VRA icon
1166
Vera Bradley
VRA
$97.8M
$231K ﹤0.01%
19,000
-51,365
-73% -$463K
CRESY
1167
Cresud
CRESY
$777M
$229K ﹤0.01%
11,534
-18,054
-61% -$338K
SAM icon
1168
Boston Beer
SAM
$1.89B
$229K ﹤0.01%
+1,200
New +$214K
APAM icon
1169
Artisan Partners
APAM
$3.03B
$225K ﹤0.01%
+5,700
New +$211K
SBCF icon
1170
Seacoast Banking Corp of Florida
SBCF
$3.36B
$222K ﹤0.01%
+8,800
New +$220K
BBG
1171
DELISTED
Bill Barrett Corp
BBG
$222K ﹤0.01%
+43,200
New +$221K
USDP
1172
DELISTED
USD PARTNERS LP
USDP
$221K ﹤0.01%
19,640
EZU icon
1173
iShare MSCI Eurozone ETF
EZU
$9.84B
$217K ﹤0.01%
+5,000
New +$217K
SRPT icon
1174
Sarepta Therapeutics
SRPT
$1.77B
$217K ﹤0.01%
+3,900
New +$207K
FULT icon
1175
Fulton Financial
FULT
$4.69B
$208K ﹤0.01%
+11,600
New +$213K

Similar funds

Arrowstreet Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Arrowstreet Capital held 1,483 positions worth $41.6B, up 11% from $37.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Arrowstreet Capital deployed $2.15B of net new capital in Q4 2017, opening 402 new positions and adding to 470 existing holdings. Its largest new stake was Charter Communications: 357,363 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $1.01B trimmed.

  • Arrowstreet Capital's largest Q4 2017 buy was Charter Communications: 357,363 shares worth $120M.
  • Arrowstreet Capital added most to CVS Health in Q4 2017, an estimated $493M increase.
  • Arrowstreet Capital's biggest Q4 2017 reduction was Amazon, cutting an estimated $1.01B.
  • Arrowstreet Capital fully exited American International in Q4 2017, selling an estimated $285M.
  • Arrowstreet Capital's ten largest holdings make up 17% of its $41.6B portfolio in Q4 2017.
  • Arrowstreet Capital opened 402 new positions and closed 268 in Q4 2017.
  • Arrowstreet Capital's portfolio value rose 11% quarter-over-quarter to $41.6B.

Based on Arrowstreet Capital's 13F filing for Q4 2017, filed 9 Feb 2018.